In this review, we showed that BB and BiB may have beneficial roles on obesity-, MetS- and T2DM-related outcomes, mainly due to positive effects in glucose tolerance, endothelial function, hepatic steatosis, and decreased NF-kB activity. This evidence concerns the gene NFKB1 and metabolic syndrome.